Yang Zheng

Title: Innovative Contributions of Inventor Yang Zheng

Introduction: Yang Zheng, an accomplished inventor based in Taizhou, China, has made significant strides in the field of pharmaceuticals. With one patent to his name, Zheng's innovative methods reflect his expertise and dedication to enhancing drug synthesis processes.

Latest Patents: Zheng's notable patent, titled "Method for preparing lisinopril intermediate," outlines a comprehensive process for synthesizing a key intermediate in the production of lisinopril, an important medication used to treat hypertension. The method involves treating (R)-hydroxy-4-phenylbutyrate with sulfonyl chloride in an organic solvent in the presence of a base to generate a sulfonate solution. This solution is then reacted with a salt of trifluoroacetyl lysine, culminating in the isolation of N-[1-(S)-alkoxycarbonyl-3-phenylpropyl]-N-trifluoroacetyl-L-lysine. This innovative approach boasts a shorter synthesis route, operational simplicity, low cost, and suitability for industrial production, showcasing Zheng's impact on pharmaceutical manufacturing.

Career Highlights: Yang Zheng has honed his skills at prominent companies, including Zhejiang Huahai Pharmaceutical Co., Ltd. and Zhejiang Huahai Tiancheng Pharmaceuticals Co., Ltd. His tenure at these organizations has equipped him with valuable experience in pharmaceutical development and innovation.

Collaborations: Throughout his career, Zheng has collaborated with fellow professionals, including Songqing Wang and Peng Dong. These partnerships have likely contributed to his inventive process and the successful formulation of his patent.

Conclusion: Yang Zheng's contributions to the field of pharmaceuticals through his patent for preparing a lisinopril intermediate exemplify his role as an innovative inventor. His effective methods and valuable experience continue to influence the pharmaceutical industry, offering more efficient solutions for drug production. As he pursues further innovations, Zheng is poised to make even greater contributions to future advancements in medicine.